Table 2. Relative expression of serum miRNAs between women with PCOS and control subjects (2-ΔCt).
miRNA | PCOS (n = 21) | Control (n = 21) | PCOS/Control fold change | P-value | ||||||
---|---|---|---|---|---|---|---|---|---|---|
ΔCt | Mean | SD | Median | ΔCt | Mean | SD | Median | |||
has-miRNA-324-3p | 5.72 | 2.32×10−2 | 1.44×10−2 | 1.82×10−2 | 5.43 | 6.94×10−2 | 1.67×10−1 | 1.79×10−2 | 0.82 | 0.516 |
has-miRNA-4522 | 8.87 | 2.27×10−3 | 7.61×10−4 | 2.44×10−3 | 8.65 | 4.48×10−3 | 1.01×10−2 | 2.14×10−3 | 0.85 | 0.405 |
has-miRNA-6767-5p | 15.63 | 4.19×10−5 | 4.64×10−5 | 2.08×10−5 | 14.27 | 9.85×10−5 | 1.21×10−4 | 6.91×10−5 | 0.39 | 0.027 |
miRNA, microRNA; PCOS, polycystic ovary syndrome; Ct, the threshold cycle; SD, standard deviation.